Back to the peptide atlas
Endocrine signalsPeptideNot FDA/EMA approved

Hexarelin

Ghrelin secretagogue

Also known as: Examorelin · Growth hormone-releasing peptide

No account · this device only

The essentials at a glance

Classification
Peptide · Endocrine signals
Mechanism
Ghrelin receptor agonist and GH secretagogue
Evidence
Preclinical
Status
Not FDA/EMA approved

Is researched for growth-hormone release and possible cardiometabolic signalling.

Distinction: Hexarelin is additionally discussed in the context of cardiometabolic signalling, unlike other secretagogues with a narrower focus.

Prohibited or covered under WADA rules in competitive sport.

Evidence strengthPreclinical

Available data come mostly from animal or cell models; robust human efficacy and safety data are lacking.

Not FDA/EMA approved: No FDA- or EMA-approved medicinal product; efficacy and safety are not established.

Research questions

Mechanism: Hexarelin

01

Ghrelin secretagogue

This checks how a substance stimulates growth hormone release through the ghrelin receptor, similar to how the body's own hunger hormone does. Measures include growth hormone peaks in blood and appetite changes.

02

Growth hormone release

This studies how much growth hormone the pituitary gland releases into the blood after a stimulus, similar to measuring how much water flows out when a tap is briefly opened. Researchers typically draw blood samples at several time points to capture the size and timing of the release.

03

Growth-axis amplification

Researchers study how a substance amplifies the natural hormone chain from brain to pituitary to growth hormone, rather than supplying growth hormone directly. Hormone levels over time and muscle or fat mass are measured.

Simple example

Research-only molecule

Think of it like a component still being tested in a development workshop, not yet cleared for general use.

Research status means efficacy, dosing, and safety in humans are not yet conclusively established.

Community themes

How communities discuss it

Personal experience reports and vendor marketing from communities are not scientific proof of efficacy.

Bodybuilding forums

Here, muscle growth, strength gains, and recovery times are compared between different growth and repair peptides, often based on personal training logs. Vendor and user claims about muscle gains are anecdotal experience, not controlled study results.

Doping and sports forums

The use of performance-enhancing peptides in sport is discussed, including experiences with competition testing and regulatory ban lists. Personal experience does not establish efficacy or safety and does not replace official rule checks.

Source and purity discussion

Discussion covers which vendors are seen as more trustworthy and how purity test results differ between batches. Such community assessments are based on limited samples and do not replace independent lab testing of each individual batch.

Evidence boundary

The evidence base is mostly from animal and cell models.

No peptide sales or individual recommendations. A separately labelled community area documents third-party protocol claims without medically endorsing them.

Primary sources

Regulators, trial registries and scientific databases support the classification and carry more weight than vendor or community claims.